NRG Oncology Foundation Inc.

Philadelphia, PA

UEI
TUS8D6ZGL9R3
CAGE
6U0M3
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Non-Profit Organization
  • Foundation
Entity structure
Corporate Entity (Tax Exempt)
SAM.gov registration date
Physical address
1600 John F Kennedy Blvd #1020, Philadelphia, PA 19103, USA
Website
nrgoncology.org
Founded
2014
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Life Sciences Tools & Services
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Grant subawards

Prime recipient Prime award Amount Awarded
University Of California, LOS Angeles The NRG Oncology Statistical Data and Manageent Cernter (SDCM), residing within the University of Pittsburgh, will manage, oversee, and be responsible for the… R01CA282416 $41,149
NRG Oncology Foundation Inc. Nctn U10CA180868 $8,514,815
NRG Oncology Foundation Inc. Nctn U10CA180868 $9,515,229
NRG Oncology Foundation Inc. NRG Oncology NCORP Research Base UG1CA189867 $1,932,232
The Ohio State University The NRG Oncology Statistical Data and Manageent Cernter (SDCM), residing within the University of Pittsburgh, will manage, oversee, and be responsible for the… R01CA276222 $64,761

Similar vendors

Vendor Location Primary NAICS
Nasbp Foundation UEI M92ZE7LVHV11 Pittsburgh, PA —
Center For Research UEI Z6JSBD9CD339 South Miami, FL 622110 General Medical and Surgical Hospitals
DHR Health Institute For Research & Development UEI VKAYFYCYBFL8 Edinburg, TX —
Stichting Nki-Avl UEI JSPLXWM8LFQ9 Amsterdam, NH 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Radiation Therapy Oncology Group UEI JD8DPSN9GGG5 Pittsburgh, PA —

About the company

NRG Oncology Foundation Inc., doing business as NRG Oncology, is a non-profit organization and foundation registered to receive federal government awards since January 3, 2013. The entity primarily engages in medical research and clinical trials, focusing on oncology-related studies. As a recipient of federal grant awards, NRG Oncology Foundation Inc. conducts research projects aimed at advancing cancer treatment and improving patient outcomes. Their work encompasses various aspects of oncology, including diagnostic imaging, treatment efficacy, and patient-reported outcomes.

The organization has received both prime and sub-grant awards for its research endeavors. A notable prime grant award from the Defense Health Agency, part of the Department of Defense, supports a project investigating MRI predictors of outcomes after radiotherapy for localized prostate cancer. This five-year project grant, running from August 2019 to August 2024, exemplifies NRG Oncology's involvement in cutting-edge cancer research. As a sub-grantee, the foundation participates in the National Clinical Trials Network (NCTN) and serves as an NRG Oncology NCORP Research Base, indicating its role in coordinating and conducting clinical trials across multiple sites. Additionally, NRG Oncology collaborates with other institutions, such as The Ohio State University, in managing complex clinical trials. This collaboration involves statistical design, protocol development, data management, and analysis for oncology studies. The foundation's work encompasses various responsibilities, including building study databases, monitoring patient accrual and data submission, creating reports for data monitoring committees, and preparing results for dissemination through ClinicalTrials.gov and scientific publications.

Quick answers

Is NRG Oncology Foundation Inc. registered in SAM.gov?

Yes. NRG Oncology Foundation Inc.'s SAM.gov registration is active through September 29, 2027.

What is NRG Oncology Foundation Inc.'s most recent federal award?

NRG Oncology Foundation Inc.'s most recent federal grant award is MRI predictors of outcome after radiotherapy for localized prostate cancer (W81XWH1910451), from Defense Health Agency, on August 15, 2019.

On GovTribe

See NRG Oncology Foundation Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors